-
GEUS77702
illustra(TM) ExoProStar 1-Step (C15-1427-411)
Price: $197.06List Price: $218.95Enzymatic PCR clean up technology with illustra Exonuclease I and Alkaline Phosphatase combined in one tube to remove unincorporated primers and dNTPs. For maximum convenience comes in a single tube. -
GEUS77705
illustra(TM) ExoProStar 1-Step (C15-1427-412)
Price: $630.26List Price: $700.29Enzymatic PCR clean up technology with illustra Exonuclease I and Alkaline Phosphatase combined in one tube to remove unincorporated primers and dNTPs. For maximum convenience comes in a single tube. -
GEUS77720
illustra(TM) ExoProStar 1-Step (C15-1427-413)
Price: $2,225.27List Price: $2,472.53Enzymatic PCR clean up technology with illustra Exonuclease I and Alkaline Phosphatase combined in one tube to remove unincorporated primers and dNTPs. For maximum convenience comes in a single tube. -
GEUS77750
illustra(TM) ExoProStar 1-Step (C15-1427-414)
Price: $4,978.02List Price: $5,531.14Enzymatic PCR clean up technology with illustra Exonuclease I and Alkaline Phosphatase combined in one tube to remove unincorporated primers and dNTPs. For maximum convenience comes in a single tube. -
Ab177924-100μgIMC-EB10 (anti-FLT3) is a fully human IgG1 monoclonal antibody, targeting the FLT3 tyrosine kinase receptor (CD135) with potential antineoplastic activity. It binds to FLT3 and blocks FLT3 ligand binding to FLT3 and subsequent FLT3 phosphorylation,
-
Ab177924-10mgIMC-EB10 (anti-FLT3) is a fully human IgG1 monoclonal antibody, targeting the FLT3 tyrosine kinase receptor (CD135) with potential antineoplastic activity. It binds to FLT3 and blocks FLT3 ligand binding to FLT3 and subsequent FLT3 phosphorylation,
-
Ab177924-1mgIMC-EB10 (anti-FLT3) is a fully human IgG1 monoclonal antibody, targeting the FLT3 tyrosine kinase receptor (CD135) with potential antineoplastic activity. It binds to FLT3 and blocks FLT3 ligand binding to FLT3 and subsequent FLT3 phosphorylation,
-
Ab177924-5mgIMC-EB10 (anti-FLT3) is a fully human IgG1 monoclonal antibody, targeting the FLT3 tyrosine kinase receptor (CD135) with potential antineoplastic activity. It binds to FLT3 and blocks FLT3 ligand binding to FLT3 and subsequent FLT3 phosphorylation,
-
I412337-1mgInformation:Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against
-
I412337-25mgInformation:Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against
-
I412337-50mgInformation:Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against
-
1339178-100MG
Indinavir
Price: $706.29List Price: $784.76This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the